Search

everythinglearnresearchcommunity

for

Search:↓

Combining glucocorticoids with immunosuppressants like cyclophosphamide improves remission and reduces relapse in pemphigus patients.

Cyclophosphamide is preferred for severe cases in pediatric rheumatology and nephrology despite its side effects.

Chemotherapy causes permanent hair follicle damage by triggering stem cell loss.

Epirubicin and cyclophosphamide cause more anemia and side effects than docetaxel and cyclophosphamide, but both are equally effective.

Older age is the main risk factor for hemorrhagic cystitis after stem cell transplants.

Scalp tourniquets did not significantly prevent hair loss from chemotherapy.

Some cancer and immune system drugs can cause serious side effects, including heart, lung, nerve, and organ damage, which need careful monitoring and management.

Endoxan often causes hair loss, which usually starts in the third week of treatment.

The treatment is safe and shows promise for metastatic breast cancer.

A six-drug treatment for metastatic breast cancer showed promising results with low side effects, especially in premenopausal women.

Busulfan/cyclophosphamide and total bone irradiation are equally effective for AML transplants.

Human mesenchymal stem cells show promise for treating skin diseases, but more research is needed to improve treatments.

Digital gangrene can be an initial symptom of late-onset systemic lupus erythematosus.

A rare lupus case in Bangladesh improved with specific treatment.

Digital gangrene can be an unusual first sign of late-onset lupus.

Digital gangrene can be a rare first sign of late-onset systemic lupus erythematosus.

Digital gangrene can be an early sign of late-onset systemic lupus erythematosus.

Chemotherapy for breast cancer often causes significant and lasting hair loss.

Suppressing eIF4E can prevent hair loss from chemotherapy.

Pericardiocentesis and immunosuppressants effectively treat cardiac tamponade in pregnant women with SLE.

Capecitabine is as effective as intravenous treatments with fewer side effects, but requires careful management of Hand-foot syndrome and patient education.

Mycophenolate mofetil is safer and more effective than cyclophosphamide for treating lupus nephritis.

The drug TGU was ineffective against small cell lung cancer and caused significant bone marrow suppression.

A 9-year-old girl developed type 1 diabetes and alopecia after being treated for a rare kidney disease.

Some new drugs show potential for treating blood cancers but have serious side effects and need more research.

New treatments for lupus show promise, but more research is needed, especially for children.

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.

Catatonia can be a rare sign of lupus, needing careful diagnosis and treatment.

Antiphospholipid syndrome can severely damage adrenal glands, requiring early diagnosis and treatment.

Pregnancy can increase lupus activity, but careful planning and treatment can improve outcomes.